THBS2-AS1: A Potential Drug Target and Biomarker (G101929523)

Target Name: THBS2-AS1

NCBI ID: G101929523

Other Name(s): THBS2 antisense RNA 1

THBS2-AS1: A Potential Drug Target and Biomarker

THBS2-AS1, also known as THBS2-associated RNA 1, is a non-coding RNA molecule that has been identified using RNA sequencing (RNA-seq) experiments as highly expressed in various tissues and organs, including brain, heart, and liver. Its highly expressed status in these tissues suggests that it may play an important role in the development and maintenance of these tissues, and thus it may be a potential drug target or biomarker.

The THBS2 gene is located on chromosome 16 and encodes a protein known as THBS2, which is a member of the superfamily of RNA-binding proteins known as AP-1/TAZ. THBS2 is highly expressed in various tissues and organs, including brain, heart, and liver, and has been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

To further investigate the functions of THBS2 and its potential as a drug target, researchers have used RNA-seq experiments to study its expression patterns in various tissues and organs. They have found that THBS2 is highly expressed in the brain, and its expression levels are significantly increased in the context of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Furthermore, studies have shown that THBS2 is involved in the regulation of various cellular processes, including cell adhesion, migration, and survival. It has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Given the potential involvement of THBS2 in various diseases, it is a promising target for drug development. Researchers have identified several potential drug candidates that can inhibit THBS2 function, including small molecules, peptides, and proteins. These compounds have been tested in various in vitro and in vivo models and have shown promise in preventing the development of various diseases.

In addition to its potential as a drug target, THBS2 has also been identified as a potential biomarker for various diseases. Its highly expressed status in various tissues and organs suggests that it may be a useful biomarker for monitoring the progression of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Overall, THBS2-AS1 is a promising target for drug development and a potential biomarker for various diseases. Further research is needed to fully understand its functions and potential as a drug and biomarker.

Protein Name: THBS2 Antisense RNA 1

More Common Targets